Clinicians are using AI without guidance. What are the risks?
Unregulated AI use could leave healthcare institutions vulnerable to HIPAA violations, cyberattacks, experts say.
Maia is a Minnesota-based senior reporter and founding reporter of Healthcare Brew, where she covers the pharmacy industry, women’s health, digital health, and how venture capital is shaping healthcare. She previously worked as a fellow covering the aerospace industry at Insider, as well as a healthcare reporter for Becker's Hospital Review. She has won an award from the Society of Professional Journalists for her work.
Unregulated AI use could leave healthcare institutions vulnerable to HIPAA violations, cyberattacks, experts say.
Companies are looking at combining several hormone-like molecules to boost results.
Though each state is allowed to create its own initiatives, there are some common themes nationwide.
The program has become a hot topic as government spending on it continues to rise.
The company has set lofty goals, including decarbonizing its value chain by 2030.
We spoke with leaders on how they’ve fared so far this year and what they’re focused on next.
The sector’s landscape has changed rapidly in the last few years.
The new name opens research on the condition up to more NIH funding, an expert explains.
The company wants to keep physicians in the field of medicine for as long as possible, she said.
The Trump administration has paused new enrollment in the areas for six months.